Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

ASX/AFP stock hub

ASX/AFP has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ASX/AFPis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

315.7M

Australian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

ASX/AFP

In the news

Latest news · ASX/AFP

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E21.3

P25 12.9P50 20.4P75 41.2

Trailing P/E20.6

P25 14.2P50 19.2P75 35.1

ROE18.3

P25 -118.7P50 -49.4P75 -1.2

ROIC13.9

P25 -74.7P50 -33.5P75 0.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ASX/AFP market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

227

Groups with data

Currency

NZD

Showing 227 of 227 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	New Zealand
Country code	AU
Employees	119
Employees Change	9%
Employees Change Percent	8.18
Enterprise value	AUD 336M
Exchange	Australian Securities Exchange
Financial currency	NZD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	NZAFTE0001S4
Last refreshed	2026-05-10
Market cap	AUD 315.7M
Price	AUD 3.19
Price currency	AUD
Rev Per Employee	1,740,542.87x
Sector	Healthcare
Sic	2834
Symbol	asx/AFP
Website	https://www.aftpharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.85%
EV Earnings	21.96x
EV/EBIT	16.89x
EV/EBITDA	15.67x
EV/FCF	42.09x
EV/Sales	1.73x
FCF yield	2.53%
Forward P/E	21.28x
P/B ratio	3.67x
P/E ratio	20.64x
P/S ratio	1.52x
PE Ratio10 Y	33.91x
PE Ratio3 Y	23.1x
PE Ratio5 Y	25.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	10.24%
EBITDA Margin	10.68%
FCF margin	3.85%
Gross margin	44.53%
Gross Profit	AUD 92.2M
Gross Profit Growth	14.71%
Gross Profit Growth Q	37.27%
Gross Profit Growth3 Y	6.02%
Gross Profit Growth5 Y	7.59%
Net Income	AUD 15.3M
Net Income Growth	50.31%
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Net Income Growth3 Y	3.78%
Net Income Growth5 Y	10.37%
Pretax Margin	9.87%
Profit Margin	7.38%
Profit Per Employee	AUD 128,531
Profitable Years	6
ROA	9.46
Roa5y	8.62
ROCE	23.98
ROE	18.27
Roe5y	23.3
ROIC	13.9
Roic5y	16.02

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	2.62%
Cagr1y	37.31%
Cagr3y	0.61%
Cagr5y	-2.52%
EPS Growth	59.08
EPS Growth Quarters	2
EPS Growth Years	0
EPS Growth3 Y	2.82
EPS Growth5 Y	9.75
FCF Growth	-64.38%
FCF Growth Q	-90.2%
FCF Growth3 Y	-31.84%
FCF Growth5 Y	-4.45%
OCF Growth	-63.88%
OCF Growth Q	-89.07%
OCF Growth10 Y	4.47%
OCF Growth3 Y	-31.44%
OCF Growth5 Y	-4.37%
Revenue Growth	19.01x
Revenue Growth Q	32.56x
Revenue Growth Quarters	21x
Revenue Growth Years	12x
Revenue Growth3 Y	6.53x
Revenue Growth5 Y	8.57x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	AUD 1.48
Assets	AUD 150.5M
Cash	AUD 10.6M
Current Assets	AUD 88M
Current Liabilities	AUD 58.2M
Debt	AUD 33.2M
Debt EBITDA	AUD 1.45
Debt Equity	AUD 0.39
Debt FCF	AUD 4.16
Equity	AUD 85.9M
Interest Coverage	8.98
Liabilities	AUD 64.6M
Long Term Assets	AUD 62.4M
Long Term Liabilities	AUD 6.3M
Net Cash	AUD -22.6M
Net Cash By Market Cap	AUD -7.16
Net Debt EBITDA	AUD 1.02
Net Debt Equity	AUD 0.26
Net Debt FCF	AUD 2.83
Tangible Book Value	AUD 34M
Tangible Book Value Per Share	AUD 0.32
WACC	6.33

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.51
Inventory Turnover	2.48
Net Working Capital	AUD 51.8M
Quick ratio	0.69
Working Capital	AUD 31.8M
Working Capital Turnover	AUD 4.55

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	7.83%
Dividend Growth	13.41%
Dividend Growth Years	3%
Dividend per share	AUD 0.02
Dividend Years	3
Dividend Yield	0.52%
Ex Div Date	2025-06-18
Last Dividend	AUD 0.02
Payout Frequency	Annual
Payout Ratio	10.82%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	29.55%
1Y total return	37.28%
200-day SMA	2.68
3Y total return	1.84%
50-day SMA	3.03
50-day SMA vs 200-day SMA	50over200
5Y total return	-11.99%
All Time High	5.25
All Time High Change	-39.24%
All Time High Date	2020-11-10
All Time Low	1.9
All Time Low Change	67.89%
All Time Low Date	2019-04-24
ATR	0.06
Beta	0.4
Ch YTD	6.33
High	3.19
High52	3.37
High52 Date	2026-01-27
High52ch	-5.34%
Low	3.19
Low52	2.2
Low52 Date	2025-08-29
Low52ch	45%
Ma50ch	5.35%
Price vs 200-day SMA	19.07%
RSI	62.73
RSI Monthly	56.2
RSI Weekly	58.45
Sharpe ratio	0.38x
Sortino ratio	0.69
Total Return	8.35%
Tr YTD	6.33
Tr1m	16.85%
Tr3m	-0.31%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	AUD 21.2M
Operating Income Growth	37.06
Operating Income Growth3 Y	-0.06
Operating Income Growth5 Y	4.22
Operating margin	10.24

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	30,477,454%
Net Borrowing	1,972,541.4
Shares Insiders	69.39%
Shares Institutions	8.18%
Shares Qo Q	9.46%
Shares Yo Y	-7.83%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	AUD 8M
Average Volume	2,040.35x
Bv Per Share	0.83
CAPEX	AUD -170,960
Ch10y	27.6
Ch1m	16.85
Ch1y	36.33
Ch3m	-0.31
Ch3y	0.31
Ch5y	-13.32
Ch6m	22.22
Change	0%
Change From Open	0
Close	3.19
Days Gap	0
Depreciation Amortization	857,483.6
Dollar Volume	191.4
Earnings Date	2026-05-20
EBIT	AUD 21.2M
EBITDA	AUD 22.1M
EPS	AUD 0.14
F Score	5
FCF	AUD 8M
FCF EV Yield	2.38x
Financing CF	-1,907,738
Fiscal Year End	March
Founded	1,997
Graham Number	1.73746
Graham Upside	-45.53
Income Tax	AUD 5.9M
Investing CF	-5,704,803
Is Primary Listing	0
Last Earnings Date	2026-02-18
Last Report Date	2025-09-30
Lynch Fair Value	AUD 1.6
Lynch Upside	-49.77
Ma150	2.74
Ma150ch	16.34%
Ma20	2.97
Ma20ch	7.52%
Net CF	461,154
Next Earnings Date	2026-05-20
Open	3.19
P FCF Ratio	39.55
P OCF Ratio	38.72
Payment Date	2025-07-04
Ppne	2,959,223.6
Price Date	2026-04-27
Price EBITDA	AUD 14.27
Ptbv Ratio	9.29
Relative Volume	0.03x
Revenue	207,124,601x
SBC By Revenue	-0x
Share Based Comp	-4,384
Tax By Revenue	2.85x
Tax Rate	28.87%
Tr6m	22.22%
Volume	60
Z Score	4.61

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

ASX/AFP dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.5%

$0.02 annual per share

Payout ratio

+10.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

3 consecutive years of growth

Total shareholder yield

+8.4%

Next ex-dividend date: 2025-06-18

Performance

ASX/AFP stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ASX/AFP?

Insider, institutional, and short-interest positioning.

Institutional ownership

+8.2%

Share of float held by funds and institutions

Insider ownership

+69.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-7.8%

Negative means the company is buying back shares.

Technical

ASX/AFP momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

62.7

Neutral momentum band

Price vs 200-day MA

+19.1%

50/200-day relationship not available

Beta (5Y)

0.40

Less volatile than the market

Sharpe ratio

0.38

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ASX/AFP

Hub-level FAQ points readers to the deeper analysis pages.

What is the current asx/AFP stock rating?

asx/AFP is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full asx/AFP analysis?

The full report lives at /stocks/asx/AFP/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for asx/AFP?

The latest report frames asx/AFP around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the asx/AFP page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.